The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...

The WHO issued guidance on long-acting lenacapavir and RDTs to support HIV PrEP implementation and simplified testing ...

When the U.S. Congress passed the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act in August 1990, it honored a ...

A once-daily oral combination therapy for HIV — bictegravir plus lenacapavir — is more effective than complex regimens are, according to results from a phase 2 study of people with HIV who are ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 ...

Despite medical advancements, HIV remains a serious public health issue in the United States, with about 30,000 new diagnoses reported each year, according to federal data. Dr. Andrew See, a ...

The United States has suspended some funding for its flagship AIDS relief program, according to international organizations and members of Congress who warn the cuts are already hurting patients and ...

KUALA LUMPUR, Malaysia — The World Health Organization has unveiled its much-anticipated new HIV treatment guidelines. Officials say the new approach will prevent 3 million deaths by 2025 and will ...

In a new Johns Hopkins Medicine-led study, researchers predict that ending federal funding for the Ryan White Program could ...